¤³¤Î¥¦¥£¥­¤ÎÆɼԤˤʤë
¹¹¿·¾ðÊ󤬥᡼¥ë¤ÇÆϤ­¤Þ¤¹¡£
¤³¤Î¥¦¥£¥­¤ÎÆɼԤˤʤë
¥«¥Æ¥´¥ê¡¼
ºÇ¶á¹¹¿·¤·¤¿¥Ú¡¼¥¸
ºÇ¿·¥³¥á¥ó¥È
Menu
¤³¤³¤Ï¼«Í³¤ËÊÔ½¸¤Ç¤­¤ë¥¨¥ê¥¢¤Ç¤¹¡£
¥Õ¥ê¡¼¥¨¥ê¥¢
¥Õ¥ê¡¼¥¨¥ê¥¢

¥Õ¥ê¡¼¥¨¥ê¥¢

¾Ã²½´ïÉÂIJ

Gardner¾É¸õ·²¡§Osteomas, dental abnormalities, Cutaneous lesions, Desmoid tumors, Congenital hypertrophy of the retinal pigment epithelium, Adrenal adenomas, Nasal angiofibromas, EXTRA-COLONIC MALIGNANCIES(Thyroid, Pancreatic, Hepatoblastoma, gallbladder and bile ducts)

Turcot¾É¸õ·²¡§FAP(autosomal dominant, APC, medulloblastomasÍ¥°Ì)

°äÅÁÀ­Èó¥Ý¥ê¥Ý¡¼¥·¥¹ÂçIJ´âHNPCC:Lynch Syndrome¡§gliomas¡¢±¦Â¦¤Ë¿¤¤¡¢¼ãǯ¡¢Â¿È¯
¥¢¥à¥¹¥Æ¥ë¥À¥à¿ÇÃÇ´ð½à²þÄû
3̾°Ê¾å¤Î·ì±ï¼Ô¤¬HNPCC´ØÏ¢´â¤ËØí´µ¤·¡¢°Ê²¼¤¹¤Ù¤Æ¹çÃ×
£±¡Ë1̾¤Ï¾¤Î2̾¤ÎÂè°ìÅÙ¶á¿Æ¼Ô¡¡£²¡Ë¾¯¤Ê¤¯¤È¤â·Ñ³¤¹¤ë2À¤Âå¡¡£³¡ËØí´µ¼Ô¤Î1̾¤Ï50ºÐ̤Ëþ¤Ç¿ÇÃÇ¡¡£´¡ËFAP½ü³°¡¡£µ¡Ë´â¤¬ÁÈ¿¥¤Ç¿ÇÃÇ
Á´ÂçIJ´â¤Ë¤ª¤±¤ë³ä¹ç²¤ÊÆ1-5%, ÆüËÜ0.2%, 0.15%
¥Ò¥È¤Î¥ß¥¹¥Þ¥Ã¥Á½¤Éü°äÅÁ»Ò(MMR gene)¤Ç¤¢¤ëhMSH2, hMLH1, hPMS1, hPMS2, hMSH6¤Ê¤É¤¬HNPCC¤Î¸¶°ø°äÅÁ»Ò
ÂçIJ°Ê³°¤Îȯ´â¡§»ÒµÜÂδ⡤°ß´â¡¤¾®Ä²´â¡¢ÃÀÆ»´â¡¤ÈçÇ¢´ï´â¡¤ÍñÁã´â¡¢Ç¾¼ðáç¡¢ÈéÉæ´â

FAPÂçIJ³°ÉÂÊѤȤ·¤Æ¤Ï¡¢ÌÖË쿧ÁǾåÈéÈîÂç¤È¤Î´ØÏ¢

Zenca¡¡¾É¸õ·²¡§°äÅÁÀ­Â¿È¯À­Æð¹üÀ­³°¹ü¼ð¤ËS ¾õ·ëIJ¥Ý¥ê¡¼¥×¤ò¹çÊ»¤·¤¿¤â¤Î

CRC±Ö³Ø
·ëIJ´â¤ÎØí´µÎ¨¡§·ëIJ´â1.5-2.5ÇÜ¡¢Ä¾Ä²´â²£¤Ð¤¤

´â¡¢Ê¿³ê¶Ú¼ð¡¢Ê¿³ê¶ÚÆù¼ð¤Ï¶õIJ¤Ë¿¤¤
»éËü𡢥«¥ë¥Á¥Î¥¤¥É¤Ï²óIJ¤Ë¿¤¤

Èó¼ðáçÀ­¥Ý¥ê¡¼¥×
²á¸í¼ðÀ­¡¡¼ãǯÀ­¥Ý¥ê¡¼¥×¡§¡½³ÈÄ¥¤·¤¿Ç¹Ë¦¾õ¤ÎÁ£´É¡¢¤¦¤Ã·ì¤Î¤¿¤á½Ð·ì¤·¤ä¤¹¤¤¡£FJP¤Ï¤Þ¤ì¤Ç¡¢SMAD4°äÅÁ»Ò¤Ë°Û¾ï¤¢¤ê´â²½¤·¤ä¤¹¤¤¡£

Èó°äÅÁÀ­¥Ý¥ê¥Ý¡¼¥·¥¹
Cronkhite-Canada¾É¸õ·²¡§¤¤¤¯¤é¤ò¤Þ¤­»¶¤é¤·¤¿¤è¤¦¤Ê¥Ý¥ê¡¼¥×¡¤È¯¾ÉǯÎ𡢿ïȼ¾É¾õ¤Ï

°äÅÁÀ­Èó¼ðáçÀ­¥Ý¥ê¥Ý¡¼¥·¥¹
Peutz-Jeghers¾É¸õ·²¡¡²á¸í¼ð¡¡¾ïÀ÷¿§ÂÎÍ¥À­¡¡LKB1°äÅÁ»ÒÊÑ°Û¡£Â¾Â¡´ï¹çÊ»¾É¡§ÍñÁã´â¡¢»ÒµÜðôÉôÁ£´â¡¢Æý¤¬¤ó¡¢ç¹´â

CowdenÉ¡§¾ïÀ÷¿§ÂÎÍ¥À­¡¤ÈéÉ桤ǴËì¤Ë²á¸í¼ð¡¢PTEN°äÅÁ»ÒÊÑ°Û80¡ó

Chilaiditi¾É¸õ·²¡§Ä²´ÉÆ⥬¥¹¤Î°Û¾ïÃùα¤òÍ褿¤¹½ê¸«¤Ç¡¢Ä²´ÉÆ⥬¥¹¤¬´Î±¦ÍդȲ£³ÖËì¤Î´Ö¤Ë°ÌÃÖ¤·¤Æ¤¤¤ë

£±¡Ë´¶À÷·¿¿©ÃæÆÇ
­¡À¸ÂÎÆâÆÇÁÇ·¿¡§¥³¥ì¥é¡¢½Ð·ìÀ­ÂçIJ¶Ý
¥³¥ì¥é¡§¾®Ä²Æâ¤Ë¤È¤É¤Þ¤Ã¤Æ³°ÆÇÁǤò»ºÀ¸¤¹¤ë¤³¤È¤Ç¼ï¡¹¤ÎÉÂÂÖ¤ò¼æµ¯¤¹¤ë¡¢ÀøÉú´ü4 Æü¡¢
IJ´É½Ð·ìÀ­ÂçIJ¶ÝO157¡§µíÆù¤äÀ¸¤ÎµíÆý¡¢²Æ´ü¡¢2¡Á7 ÆüÄøÅÙ¤ÎÀøÉú´ü

­¢¿¯Æþ·¿¡§Ä²±ê¥Ó¥Ö¥ê¥ª¡¢¥µ¥ë¥â¥Í¥é¡¢Ä²¥Á¥Õ¥¹¡¢¥«¥ó¥Ô¥í¥Ð¥¯¥¿¡¼¡¢ÀÖΡ
IJ±ê¥Ó¥Ö¥ê¥ª¿©ÃæÆÇ¡§»É¿È¡¢²Æ´ü¡¢ÀøÉú´ü¡§È¾Æü
¥µ¥ë¥â¥Í¥é¶Ý¿©ÃæÆÇ,¡§¥ê¥ó¥ÑÁÈ¿¥(¥Ñ¥¤¥¨¥ëÈÄ) ¤ÇÁý¿£¡¢·ÜÆù¡¦Íñ¡¦ÆýÀ½ÉÊ¡¢1 Æü¤ÎÀøÉú´ü
IJ¥Á¥Õ¥¹¡§ÀøÉú´ü2 ½µ´Ö
¥«¥ó¥Ô¥í¥Ð¥¯¥¿¡¼¿©ÃæÆÇ¡§·ÜÆù¤äÀ¸¤ÎµíÆý¡¢ÀøÉú´ü¤¬3 Æü°Ê¾å
ºÙ¶ÝÀ­ÀÖΡ¡§ºÙ˦¿¯ÆþÀ­¤ò»ý¤Ä¤¿¤áÂçIJ¾åÈéºÙ˦¤Ë¿¯Æþ¡¢¿ôÆü´ÖÀøÉú´ü´Ö

£²¡ËÆÇÁÇ·¿¿©ÃæÆÇ¡§¥Ü¥Ä¥ê¥Ì¥¹¡¢²«¿§¥Ö¥É¥¦µå¶Ý¡¢¥¦¥§¥ë¥·¥å
¥Ü¥Ä¥ê¥Ì¥¹¶Ý¿©ÃæÆÇ¡§´ÌµÍ¡¦¥½¡¼¥»¡¼¥¸¡¢±øÀ÷˪̪¡¢·Ð¸ý12¡Á36 »þ´Ö
¥Ö¥É¥¦µå¶Ý¿©ÃæÆÇ¡§¿©¸å¤«¤é¿ô»þ´Ö
¥¦¥§¥ë¥·¥å¶Ý¿©ÃæÆÇ¡§Ä²±ê¥¨¥ë¥·¥Ë¥¢¶Ý¡ÊÀøÉú´ü3-7Æü´Ö¡Ë¤â¤·¤¯¤Ïµ¶·ë³Ë¶Ý¤Ë¤è¤ë°ßIJ±ê¡¡

Polyp features and the frequency of high-grade dysplasia
Polyp Frequency of dysplasia, percent
Tubular 2
Villous 31
Small adenomas ( 5 mm) 1
Medium-sized adenomas (6 to 10 mm) 5
Large adenomas (>1 cm) 21
Adapted from O'Brien, MJ, Winawer, SJ, Zauber, AG, et al. Gastroenterology 1990; 98:371.

æêÌçÎö¹¦6»þ¹¥È¯

ÃÁÇòϳ½ÐÀ­°ßIJ¾É¤Ë¤Ä¤¤¤Æ
¿ÇÃÇ¥¢¥ë¥´¥ê¥º¥à
£±¡ËÉâ¼ð¡¢ÄãÃÁÇò·ì¾É¡¢Ä㥢¥ë¥Ö¥ß¥ó·ì¾É¡¢²¼Î¡¤¬¤¢¤ì¤Ð¡¢¦Á1¥¢¥ó¥Á¥È¥ê¥×¥·¥óÊØÃæÇÓÝõ»î¸³¤ò¤¹¤ë(ÁýÂ礹¤ë¡¢131I-¥¢¥ë¥Ö¥ß¥ó¥·¥ó¥Á¤ÇÃÁÇòϳ½Ð¤Î̵ͭ¡¢Éô°Ì¤¬Ê¬¤«¤ë)
£²¡Ë¾åÉô¾Ã²½´ÉÆâ»ë¶À¸¡ºº¤ò¤·¤Æ¡¢
¥¬¥¹¥È¥ê¥Î¡¼¥Þ
Ç´Ëì²á·ÁÀ®¡¢ÊɺÙ˦¤Î¸º¾¯¡¢»ÀʬÈ縺¾¯¡§MenetrierÉÂ
Ç´Ëì²á·ÁÀ®¡¢ÊɺÙ˦¤ÎÁý²Ã¡¢»ÀʬÈçÁý²Ã¡§Þú½ÐÀ­°ß¾É
°ß¤ÏÀµ¾ï¡¡1)½½Æó»ØIJ¤âÀµ¾ï¡§ÂçIJ¶À¤Ë¤ÆIBD¤Ê¤É¸¡º÷¡¢2)½½Æó»ØIJ¤Ë°Ê¾å¤¢¤ì¤Ð¾®Ä²¥ê¥ó¥Ñ´É³ÈÄ¥¾É¹Í¤¨À¸¸¡
¾¤Ë¤Ï¡¢Budd-Chiari¡¢¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¡¢¼ý½ÌÀ­¿´Ëì±ê¡¢Ýµ·ìÀ­¿´ÉÔÁ´¡¢´Î¹ÅÊѤʤÉ

¥á¥Ã¥±¥ë·Æ¼¼¡§Ä²´ÉËìÉÕÃå¦ÂЦ¡¢¿¿À­

¥í¥Ú¥é¥ß¥É¡§¥µ¥¤¥¯¥ê¥Ã¥¯AMP¤ò²ð¤·¤Æ»ßΡºîÍѤ«

ÄÙáçÀ­ÂçIJ±ê¡§ç¹±ê¤ÎIJ´É³°¹çÊ»¾É¤Ë¤¢¤ë
pauchitis

IJ·ë³Ë¡§±ê¾É¤¬Ä²´É¤òÎؾõ¤Ë¼è¤ê´¬¤¯¥ê¥ó¥Ñ´É¤Ë±è¤Ã¤Æ²£Êý¸þ¤ØÇȵڤ¹¤ë

ñ½ãÀ­ÄÙá硧²óÌÕÉô¤ËÎà±ß·Á¤ÎÂǤÁÈ´¤­ÍÍÄÙáç¤ò·ÁÀ®

ÀÖΡ¥¢¥á¡¼¥Ð¡¡PAS
Æâ»ë¶ÀÁü

ÂçIJm´â¡¢SM´â¡¤MP´â¥ê¥ó¥ÑÀáž°ÜΨ¡§0%¡¢10¡ó¡¤20¡óÄøÅÙ
2008ǯ08·î12Æü(²Ð) 00:51:54 Modified by ndigerg




¥¹¥Þ¡¼¥È¥Õ¥©¥óÈǤǸ«¤ë